Mangoceuticals (MGRX) Cash from Operations Growth (3y) (2026)
Mangoceuticals (MGRX) Cash from Operations Growth (3y) (2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 30.60% |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 45.52% |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 45.69% |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 102.73% |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 32.92% |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | - |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | -54.61% |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 62.21% |
| 10 | Mangoceuticals | 5.25 Mn | 5.06 Mn | 29,001.00 | 10.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.16% |